Page last updated: 2024-11-02

pamidronate and Carcinoma, Medullary

pamidronate has been researched along with Carcinoma, Medullary in 1 studies

Carcinoma, Medullary: A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)

Research Excerpts

ExcerptRelevanceReference
"Skeletal metastases from thyroid cancer are poorly responsive to medical or radioiodine treatment."2.70Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer. ( Abbruzzese, A; Caraglia, M; Ciccarelli, A; Fonderico, F; Lupoli, G; Martignetti, A; Nuzzo, V; Vitale, G, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vitale, G1
Fonderico, F1
Martignetti, A1
Caraglia, M1
Ciccarelli, A1
Nuzzo, V1
Abbruzzese, A1
Lupoli, G1

Trials

1 trial available for pamidronate and Carcinoma, Medullary

ArticleYear
Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer.
    British journal of cancer, 2001, Jun-15, Volume: 84, Issue:12

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Analgesics; Anti-Inflammatory Agents; Bone Neoplasms; Bone

2001